BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38072524)

  • 21. MicroRNA-124 represses wound healing by targeting SERP1 and inhibiting the Wnt/β-catenin pathway.
    Zhang G; Song K; Yan H
    Adv Clin Exp Med; 2019 Jun; 28(6):711-718. PubMed ID: 30740945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taurine is an effective therapy against thiram induced tibial dyschondroplasia via HIF-1α/VEGFA and β-catenin/ GSK-3β pathways in broilers.
    Ding Y; Yao W; Fakhar-E-Alam Kulyar M; Mo Q; Pan H; Zhang Y; Ma B; He Y; Zhang M; Hong J; Waqas M; Li J
    Ecotoxicol Environ Saf; 2021 Nov; 228():112981. PubMed ID: 34781124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the tibial growth plates of chickens with thiram-induced dyschondroplasia.
    Rath NC; Richards MP; Huff WE; Huff GR; Balog JM
    J Comp Pathol; 2005 Jul; 133(1):41-52. PubMed ID: 15899490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.
    Poodineh J; Sirati-Sabet M; Rajabibazl M; Ghasemian M; Mohammadi-Yeganeh S
    Chem Biol Drug Des; 2022 Sep; 100(3):334-345. PubMed ID: 35797350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-409-3p promotes osteoblastic differentiation via activation of Wnt/β-catenin signaling pathway by targeting SCAI.
    Chen N; Yang H; Song L; Li H; Liu Y; Wu D
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33274736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angelica sinensis polysaccharide suppresses the Wnt/β-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p/PCDH10 axis.
    Cai Y; Wang Y; Su W; Zhou X; Lu C
    Biochem Pharmacol; 2024 Jul; 225():116295. PubMed ID: 38762145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
    Wei RJ; Zhang CH; Yang WZ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-138 induces cell survival and reduces WNT/β-catenin signaling of osteoarthritis chondrocytes through NEK2.
    Xu W; Gao P; Zhang Y; Piao L; Dong D
    IUBMB Life; 2019 Sep; 71(9):1355-1366. PubMed ID: 31034758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Dong ZC; Zhang D; Wang SB; Lin ZQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3018-3026. PubMed ID: 29863246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-19b-3p Inhibits Hypoxia-Ischemia Encephalopathy by Inhibiting SOX6 Expression via Activating Wnt/β-catenin Pathway.
    Zeng H; Chen YX
    Neurochem Res; 2023 Mar; 48(3):874-884. PubMed ID: 36369428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-424-5p shuttled by bone marrow stem cells-derived exosomes attenuates osteogenesis via regulating WIF1-mediated Wnt/β-catenin axis.
    Wei Y; Ma H; Zhou H; Yin H; Yang J; Song Y; Yang B
    Aging (Albany NY); 2021 Jul; 13(13):17190-17201. PubMed ID: 34229300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
    Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose mesenchymal stem cells-derived exosomes alleviate osteoarthritis by transporting microRNA -376c-3p and targeting the WNT-beta-catenin signaling axis.
    Li F; Xu Z; Xie Z; Sun X; Li C; Chen Y; Xu J; Pi G
    Apoptosis; 2023 Apr; 28(3-4):362-378. PubMed ID: 36396777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway.
    Chen S; Sun YY; Zhang ZX; Li YH; Xu ZM; Fu WN
    Oncotarget; 2017 Feb; 8(9):14708-14718. PubMed ID: 28122350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-1 Modulates Chondrocyte Phenotype by Regulating FZD7 of Wnt/ β-Catenin Signaling Pathway.
    Yang Y; Wang Y; Jia H; Li B; Xing D; Li JJ
    Cartilage; 2021 Dec; 13(2_suppl):1019S-1029S. PubMed ID: 33215510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted inhibition of β-catenin by miR-320 and decreased MMP-13 expression in suppressing chondrocyte collagen degradation.
    Zhang HX; Sun C; Yu HC; Song B; Pan ZX
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5828-5835. PubMed ID: 30280762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-520e targets AEG-1 to suppress the proliferation and invasion of colorectal cancer cells through Wnt/GSK-3β/β-catenin signalling.
    Lv S; Zhang J; He Y; Liu Q; Wang Z; Liu B; Shi L; Wu Y
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):158-167. PubMed ID: 31574178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of baicalein on Wnt/β-catenin pathway and miR-25 expression in Saos-2 osteosarcoma cell line.
    Örenlili Yaylagül E; Ülger C
    Turk J Med Sci; 2020 Jun; 50(44):1168-1179. PubMed ID: 32283909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.